Daniel Teo - Herborium Sr Devel

HBRMDelisted Stock  USD 0.0001  0.00  0.00%   

Insider

Daniel Teo is Sr Devel of Herborium Group
Phone201-849-4431
Webhttps://www.herborium.com
Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey. Herborium operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2 people. Herborium Group [HBRM] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). Herborium is listed under Pharmaceutical Products category by Fama And French industry classification.

Herborium Group Leadership Team

Elected by the shareholders, the Herborium's board of directors comprises two types of representatives: Herborium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Herborium. The board's role is to monitor Herborium's management team and ensure that shareholders' interests are well served. Herborium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Herborium's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Donahue, Controller Advisor
Dr MSIB, Scientific CoFounder
Lawrence Woo, Asia Director
Daniel Teo, Sr Devel
Agnes Olszewski, President CEO, Acting CFO, Director
Roger Jones, UK Director

Herborium Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Herborium a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Herborium Pink Sheet

If you are still planning to invest in Herborium Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herborium's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets